Show simple item record

Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients

dc.contributor.authorSzwedo, Aleksandra A.
dc.contributor.authorPedersen, Camilla Christina
dc.contributor.authorUshakova, Anastasia
dc.contributor.authorForsgren, Lars
dc.contributor.authorTysnes, Ole-Bjørn
dc.contributor.authorCounsell, Carl E.
dc.contributor.authorAlves, Guido
dc.contributor.authorLange, Johannes
dc.contributor.authorMacleod, Angus D.
dc.contributor.authorMaple-Grødem, Jodi
dc.date.accessioned2021-02-10T10:30:02Z
dc.date.available2021-02-10T10:30:02Z
dc.date.issued2021-02-10
dc.identifier187505708
dc.identifierf5a0229a-ed5d-4da9-847b-a16f8060852a
dc.identifier33643180
dc.identifier000620982000001
dc.identifier85101618880
dc.identifier.citationSzwedo , A A , Pedersen , C C , Ushakova , A , Forsgren , L , Tysnes , O-B , Counsell , C E , Alves , G , Lange , J , Macleod , A D & Maple-Grødem , J 2021 , ' Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients ' , Frontiers in Neurology , vol. 11 , 620585 . https://doi.org/10.3389/fneur.2020.620585en
dc.identifier.issn1664-2295
dc.identifier.otherBibtex: 10.3389/fneur.2020.620585
dc.identifier.urihttps://hdl.handle.net/2164/15812
dc.descriptionFUNDING Funding sources for the respective studies are as follows: The Norwegian ParkWest study has been funded by the Research Council of Norway (177966), the Western Norway Regional Health Authority (911218), and the Norwegian Parkinson’s Disease Association. PINE study was supported by Parkinson’s UK (G0502, G0914, and G1302), Scottish Government Chief Scientist Office, BMA Doris Hillier Award, the BUPA Foundation, NHS Grampian Endowments, and RS MacDonald Trust. The Swedish Medical Research Council, the Swedish Parkinson’s Disease Association, the Swedish Parkinson’s Foundation, Erling Persson Foundation, Kempe Foundation, and the Västerbotten County Council have funded the NYPUM study. The Research Council of Norway (287842) supported AS, JM-G, and GA. ACKNOWLEDGMENTS The authors would like to thank all of the patients and controls for participation in each of the studies. Equally, we thank all members of each of the study groups and other personnel for their contributions.en
dc.format.extent7
dc.format.extent338687
dc.language.isoeng
dc.relation.ispartofFrontiers in Neurologyen
dc.subjectSNCAen
dc.subjectParkinson diseaseen
dc.subjectdisease progressionen
dc.subjectGenetic associationen
dc.subjectcognitive impairmenten
dc.subjectParkinson's diseaseen
dc.subjectgenetic associationen
dc.subjectParkinson&aposen
dc.subjects diseaseen
dc.subjectRC Internal medicineen
dc.subjectR Medicineen
dc.subjectClinical Neurologyen
dc.subjectNeurologyen
dc.subjectParkinson's UKen
dc.subjectG0502en
dc.subjectG0914en
dc.subjectG1302en
dc.subjectChief Scientist Office (CSO)en
dc.subjectSupplementary Dataen
dc.subject.lccRCen
dc.subject.lccRen
dc.titleAssociation of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patientsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.description.statusPeer revieweden
dc.identifier.doi10.3389/fneur.2020.620585
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85101618880&partnerID=8YFLogxKen
dc.identifier.urlhttps://www.frontiersin.org/articles/10.3389/fneur.2020.620585/full#supplementary-materialen
dc.identifier.vol11en


Files in this item

Thumbnail
Name:
Szwedo_et_al_FiN_AssociationOf ...
Size:
330.7Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record